Cargando…
Co-treatment by docetaxel and vinblastine breaks down P-glycoprotein mediated chemo-resistance
OBJECTIVE(S): Chemoresistance remains the main causes of treatment failure and mortality in cancer patients. There is an urgent need to investigate novel approaches to improve current therapeutic modalities and increase cancer patients’ survival. Induction of drug efflux due to overexpression of P-g...
Autores principales: | Mohseni, Mahsa, Samadi, Nasser, Ghanbari, Parisa, Yousefi, Bahman, Tabasinezhad, Maryam, Sharifi, Simin, Nazemiyeh, Hossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mashhad University of Medical Sciences
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834120/ https://www.ncbi.nlm.nih.gov/pubmed/27114800 |
Ejemplares similares
-
Sphingosine 1-phosphate interacts with Survivin pathway to enhance tumorigenesis in cancer cells
por: Tabasinezhad, Maryam, et al.
Publicado: (2015) -
Regulation of initial vinblastine influx by P-glycoprotein.
por: Shalinsky, D. R., et al.
Publicado: (1993) -
Prior anti-CAFs break down the CAFs barrier and improve accumulation of docetaxel micelles in tumor
por: Pang, Ning, et al.
Publicado: (2018) -
Vinblastine in the treatment of Hodgkin's disease.
por: Jelliffe, A. M.
Publicado: (1969) -
Inhibition of interferon secretion by vinblastine
por: Havell, EA, et al.
Publicado: (1975)